Follow the people · Insider
Zhenya Lindgardt
Zhenya Lindgardt files insider transactions with the SEC as a chief executive officer of Sera Prognostics. We hold 5 disclosed purchases and sales filed since 9 November 2021, 2 of them in the last 90 days.
- Files forSERA
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure9 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 November 2021 — 8 September 2026Chief Executive Officer · Sera Prognostics 36 Form 4 lines · source: SEC Form 4
Every transaction
36 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 8 Sep 2026 | 9 Sep 2026SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 20,139 shares | down −0.5% | up +0.0% |
| 11 Jun 2026 | 15 Jun 2026SEC Form 4 | 4 d | sold on the open market | Sera Prognostics | 6,990 shares | up +3.6% | up +8.7% |
| 9 Jun 2026 | 10 Jun 2026SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 20,755 shares | down −6.1% | up +0.0% |
| 12 Mar 2026 | 13 Mar 2026SEC Form 4 | 1 d | was grantednot a trade | Sera Prognostics | 154,440 shares | up +0.5% | down −6.1% |
| 12 Mar 2026 | 13 Mar 2026SEC Form 4 | 1 d | was grantednot a trade | Sera Prognosticsderivative | 239,442 shares | up +0.5% | down −6.1% |
| 12 Mar 2026 | 13 Mar 2026SEC Form 4 | 1 d | was grantednot a trade | Sera Prognosticsderivative | 239,442 shares | up +0.5% | down −6.1% |
| 12 Mar 2026 | 13 Mar 2026SEC Form 4 | 1 d | was grantednot a trade | Sera Prognostics | 154,440 shares | up +0.5% | down −6.1% |
| 11 Mar 2026 | 12 Mar 2026SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 2,973 shares | up +3.6% | up +0.5% |
| 11 Mar 2026 | 12 Mar 2026SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 2,973 shares | up +3.6% | up +0.5% |
| 10 Mar 2026 | 12 Mar 2026SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 22,639 shares | up +9.3% | up +0.5% |
| 10 Mar 2026 | 12 Mar 2026SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 22,639 shares | up +9.3% | up +0.5% |
| 10 Dec 2025 | 11 Dec 2025SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 4,155 shares | down −41.2% | down −41.2% |
| 9 Dec 2025 | 10 Dec 2025SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 28,215 shares | down −34.9% | down −41.2% |
| 10 Nov 2025 | 12 Nov 2025SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 11,594 shares | down −21.6% | down −35.9% |
| 11 Sep 2025 | 12 Sep 2025SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 3,246 shares | down −34.9% | down −35.5% |
| 9 Sep 2025 | 9 Sep 2025SEC Form 4 | 0 d | sold on the open market | Sera Prognostics | 21,158 shares | down −35.5% | down −35.5% |
| 8 Aug 2025 | 11 Aug 2025SEC Form 4 | 3 d | sold on the open market | Sera Prognostics | 8,571 shares | down −19.4% | down −14.5% |
| 10 Jun 2025 | 11 Jun 2025SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 3,344 shares | up +34.2% | up +33.3% |
| 9 Jun 2025 | 11 Jun 2025SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 23,042 shares | up +33.3% | up +33.3% |
| 8 May 2025 | 9 May 2025SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 9,406 shares | down −5.7% | down −9.9% |
| 7 Mar 2025 | 10 Mar 2025SEC Form 4 | 3 d | sold on the open market | Sera Prognostics | 29,722 shares | down −53.7% | down −51.7% |
| 6 Mar 2025 | 10 Mar 2025SEC Form 4 | 4 d | was grantednot a trade | Sera Prognosticsderivative | 181,380 shares | down −51.8% | down −51.7% |
| 6 Mar 2025 | 10 Mar 2025SEC Form 4 | 4 d | was grantednot a trade | Sera Prognostics | 126,920 shares | down −51.8% | down −51.7% |
| 12 Feb 2025 | 14 Feb 2025SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 14,075 shares | down −53.4% | down −50.4% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 26,224 shares | down −75.7% | down −76.6% |
| 11 Nov 2024 | 12 Nov 2024SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 12,075 shares | down −73.1% | down −72.4% |
| 10 Sep 2024 | 10 Sep 2024SEC Form 4 | 0 d | sold on the open market | Sera Prognostics | 25,085 shares | down −73.0% | down −73.0% |
| 7 Aug 2024 | 8 Aug 2024SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 12,327 shares | down −73.0% | down −73.0% |
| 10 Jun 2024 | 11 Jun 2024SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 26,867 shares | down −75.2% | down −76.0% |
| 8 May 2024 | 10 May 2024SEC Form 4 | 2 d | sold on the open market | Sera Prognostics | 11,992 shares | down −78.5% | down −78.4% |
| 26 Mar 2024 | 26 Mar 2024SEC Form 4 | 0 d | sold on the open market | Sera Prognostics | 38,899 shares | down −78.9% | down −78.9% |
| 6 Feb 2024 | 7 Feb 2024SEC Form 4 | 1 d | sold on the open market | Sera Prognostics | 27,997 shares | down −75.9% | down −74.7% |
| 6 Nov 2023 | 8 Nov 2023SEC Form 4 | 2 d | was grantednot a trade | Sera Prognostics | 800,000 shares | up +7.5% | up +1.5% |
| 6 Nov 2023 | 8 Nov 2023SEC Form 4 | 2 d | was grantednot a trade | Sera Prognostics | 175,000 shares | up +7.5% | up +1.5% |
| 3 Jun 2022 | 6 Jun 2022SEC Form 4 | 3 d | was grantednot a trade | Sera Prognosticsderivative | 149,675 shares | up +48.1% | up +53.8% |
| 8 Nov 2021 | 9 Nov 2021SEC Form 4 | 1 d | was grantednot a trade | Sera Prognosticsderivative | 38,325 shares | down −81.7% | down −81.9% |
Both percentages are the stock’s move, not Zhenya Lindgardt’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 36 of the 36 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.